The surgeon's role in breast cancer: Changing concepts Henry Patrick Leis Jr. Viewpoints Pages: 5 - 15
A commentary on the role of the surgeon in primary breast cancer Bernard Fisher Viewpoints Pages: 17 - 26
Estrogen receptor measurement in low-protein breast cancer cytosols Bernard L. PowellMinerva De La GarzaWilliam L. McGuire Viewpoints Pages: 33 - 35
Correlation of primary breast cancer histopathology and estrogen receptor content Edwin R. FisherC. Kent OsborneHouston C. Ford Reports Pages: 37 - 41
The interpretation of trials: Combined hormonal therapy and chemotherapy in disseminated breast cancer Stephen K. Carter US-Japan Conference on Chemoendocrine Therapy Pages: 43 - 51
Tamoxifen alone versus tamoxifen plus 1-(2-tetrahydrofuryl)-5-fluorouracil in the treatment of advanced breast cancer: A sequential trial Tomio WadaHiroki KoyamaToshio Terasawa US-Japan Conference on Chemoendocrine Therapy Pages: 53 - 58
Randomized clinical trial of tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal women with advanced breast cancer John H. GlickRichard H. CreechMichael Varano US-Japan Conference on Chemoendocrine Therapy Pages: 59 - 68
Adjuvant chemo-endocrine therapy for androgen-dependent mammary tumor in mice Naomi UchidaKenji YamaguchiKeishi Matsumoto US-Japan Conference on Chemoendocrine Therapy Pages: 69 - 75
Adjuvant therapy of stage II breast cancer Charles A. HubayOlof H. Pearson27 Participating Investigators US-Japan Conference on Chemoendocrine Therapy Pages: 77 - 82